RGTPQ — RegenETP, Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $1.14m
- -$5.21m
- $0.81m
Annual cashflow statement for RegenETP,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 October 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -65.4 | -92.5 | -42.9 | -30.2 | -7.83 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 35.6 | 32.3 | 7.3 | 3.92 | -15.8 |
Discontinued Operations | |||||
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.181 | 0.311 | -5.46 | 0.795 | -0.496 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -28.5 | -56.6 | -37.8 | -22.6 | -22.6 |
Capital Expenditures | -9.22 | -2.77 | -1.34 | -0.123 | -0.037 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2.2 | -12.8 | 19 | 0.027 | 2.58 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11.4 | -15.6 | 17.6 | -0.096 | 2.54 |
Financing Cash Flow Items | -0.03 | -0.904 | -0.155 | -0.463 | 22.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 93.3 | 26.8 | 35.4 | 16.6 | 12.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 53.3 | -45.5 | 15.3 | -6.15 | -7.93 |